Re: EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-Specific and Overall Survival in Non-Muscle-Invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin

2017 ◽  
Vol 198 (1) ◽  
pp. 39-41
Author(s):  
Sam S. Chang
Sign in / Sign up

Export Citation Format

Share Document